Testing effectiveness (Phase 2)Active Not RecruitingNCT00951535
What this trial is testing
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
Who this might be right for
Prostate Cancer
Cancer Trials Ireland 251